Description: The Benefit/Risk Ratio by M. Schafer-Korting, Hans C. Korting This handbook provides the reader with a more comprehensive look at various facets of benefit-to-risk ratio assessment. It also provides the clinician with data allowing optimization of his decisions on drug treatment. FORMAT Hardcover LANGUAGE English CONDITION Brand New Publisher Description The use of drugs as remedies for various types of diseases has a long tradition. However, it has only been recently recognized that the value of any given compound must be evaluated in light of its benefit to risk ratio. When prescribing drugs, physicians must look at the big picture of the drugs benefits in relation to its side effects and possible toxicity. The aim of this handbook is to compile data from various authors, providing clinicians with data that will optimize their decision making in selecting effective, low-risk drug treatments. Author Biography Korting, Hans C. | Schafer-Korting, M. Table of Contents The Role and Analysis of Benefit and Risk in the Development of New Drugs. Prediction of the Benefit/Risk Ratio from In Vitro Data. Evaluation of Therapeutic Benefits and Toxicological Risks Using Structure-Activity Relational Expert Systems. Improving the Therapeutic Index Through Unusual Routes of Application: Intra-Arterial Treatment of Liver Metastases. Establishing the Benefit/Risk Ration with Combination Drugs. Improving the Therapeutic Index of Antineoplastic Agents through Additional Drugs. Antihypertensive Agents. Diueretics. Anti-Diabetic Drugs. Anticonvulsant Drugs and Drugs for Parkinsons Disease. Antihistamines and Antiserotonins. Cytokines and Immunomodulators. Non-Opioid Analgesics and Anti-Inflammatory Agents. Toxicity Profile of Liposomal Anthacyclines. Antibacterial Agents. Antiviral Agents. Drugs Used in Reproductive Endocrinology. Nicotine Preparations in Smoking. Systemic Drugs for Skin Diseases. Topical Liposome Drugs. Topical Glucocorticoids. Index. Review "This book appears to be one of the first to examine risk and benefits of new drugs in a more quantitative manner...this book provides a solid overview of drug types and their benefit/risk ratio...This resource would compliment the collection of most health science libraries...Of special interest to those involved with drug development and pharmacology and therapeutics."--Reviewer: Dale A. Stirling, Environmental Historian/Information Specialist, E-STREAMS, Vol. 3, No. 4 Details ISBN0849327911 Author Hans C. Korting Short Title BENEFIT/RISK RATIO Language English ISBN-10 0849327911 ISBN-13 9780849327919 Media Book Format Hardcover Illustrations Yes Year 1998 Imprint CRC Press Inc Subtitle A Handbook for the Rational Use of Potentially Hazardous Drugs Country of Publication United States Edition 1st Edited by Monika Schafer-Korting Place of Publication Bosa Roca Birth 1952 DOI 10.1604/9780849327919 UK Release Date 1998-07-24 AU Release Date 1998-07-24 NZ Release Date 1998-07-24 US Release Date 1998-07-24 Publisher Taylor & Francis Inc Publication Date 1998-07-24 Alternative 9780367447816 DEWEY 615.1901 Audience Professional & Vocational Pages 398 We've got this At The Nile, if you're looking for it, we've got it. With fast shipping, low prices, friendly service and well over a million items - you're bound to find what you want, at a price you'll love! TheNile_Item_ID:134448497;
Price: 457.69 AUD
Location: Melbourne
End Time: 2025-01-04T18:33:38.000Z
Shipping Cost: 15.46 AUD
Product Images
Item Specifics
Restocking fee: No
Return shipping will be paid by: Buyer
Returns Accepted: Returns Accepted
Item must be returned within: 30 Days
ISBN-13: 9780849327919
Book Title: The Benefit/Risk Ratio
Number of Pages: 400 Pages
Language: English
Publication Name: The Benefit/Risk Ratio: a Handbook for the RATIONAL Use of Potentially Hazardous Drugs
Publisher: Taylor & Francis Inc
Publication Year: 1998
Subject: Medicine
Item Height: 254 mm
Item Weight: 930 g
Type: Textbook
Author: Hans C. Korting, M. Schafer-Korting
Item Width: 178 mm
Format: Hardcover
